We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

65 hedge funds and large institutions have $5.75M invested in Asensus Surgical, Inc. in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,267% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $169K

104% more capital invested

Capital invested by funds: $2.81M → $5.75M (+$2.93M)

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

3% less funds holding

Funds holding: 6765 (-2)

Holders
65
Holders Change
-2
Holders Change %
-2.99%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
15
Reduced
10
Closed
12
Calls
$2.31M
Puts
$169K
Net Calls
+$2.14M
Net Calls Change
+$358K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$14K +$1.17K +2,549 +13%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$13K +$1K +2,187 +12%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$12K
Victory Capital Management
29
Victory Capital Management
Texas
$10K +$361 +790 +5%
Wolverine Trading
30
Wolverine Trading
Illinois
$9K +$6.92K +15,126 New
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$8K -$5.4K -11,809 -46%
MCP
32
Mirador Capital Partners
California
$8K +$6.19K +13,539 New
UBS Group
33
UBS Group
Switzerland
$7K -$31.1K -67,936 -85%
State Street
34
State Street
Massachusetts
$7K +1 +0%
GWM
35
Geneos Wealth Management
Colorado
$7K +$960 +2,100 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$6K
CAG
37
Csenge Advisory Group
Florida
$6K
TRCT
38
Tower Research Capital (TRC)
New York
$6K +$4.25K +9,285 New
Wells Fargo
39
Wells Fargo
California
$4K +$152 +332 +5%
Credit Agricole
40
Credit Agricole
France
$3K
Bank of America
41
Bank of America
North Carolina
$1K -$141 -308 -14%
IA
42
IFP Advisors
Florida
$1K
VFA
43
Valeo Financial Advisors
Indiana
$1K
AF
44
Advisornet Financial
Minnesota
$1K +$387 +847 +2,172%
Verition Fund Management
45
Verition Fund Management
Connecticut
-$35K -100,000 Closed
HLA
46
Hamilton Lane Advisors
Pennsylvania
-$10K -27,818 Closed
California Public Employees Retirement System
47
California Public Employees Retirement System
California
-$4K -11,101 Closed
GT
48
Glenmede Trust
Pennsylvania
-$2K -7,172 Closed
Northwestern Mutual Wealth Management
49
Northwestern Mutual Wealth Management
Wisconsin
-$167 -366 -60%
SPIA
50
Steward Partners Investment Advisory
New York
-$1 -3 -0.6%

ASXC Hedge Fund Activity: Q4 2020 in Review

65 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q4 2020, worth a combined $5.75M — up 104% from $2.81M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ASXC and 11 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 15 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $190K. The largest seller was Renaissance Technologies, cutting an estimated $231K.

  • 65 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q4 2020, down from 67 in Q3 2020.
  • Funds reported $5.75M of Asensus Surgical, Inc. stock for Q4 2020, up 104% quarter-over-quarter.
  • 11 funds opened new Asensus Surgical, Inc. positions in Q4 2020 and 12 closed out, a net change of -1 holder.
  • The largest Asensus Surgical, Inc. buyer in Q4 2020 was Millennium Management, an estimated $190K added.
  • The largest Asensus Surgical, Inc. seller in Q4 2020 was Renaissance Technologies, an estimated $231K sold.

Based on aggregated 13F filings for Q4 2020.